CN105267324A - Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny - Google Patents

Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny Download PDF

Info

Publication number
CN105267324A
CN105267324A CN201510847898.0A CN201510847898A CN105267324A CN 105267324 A CN105267324 A CN 105267324A CN 201510847898 A CN201510847898 A CN 201510847898A CN 105267324 A CN105267324 A CN 105267324A
Authority
CN
China
Prior art keywords
parts
chinese medicine
radix
traditional chinese
lumbar vertebra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510847898.0A
Other languages
Chinese (zh)
Inventor
蒋玉群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510847898.0A priority Critical patent/CN105267324A/en
Publication of CN105267324A publication Critical patent/CN105267324A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides an oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny. The oral traditional Chinese medicine comprises the following components in parts by weight: 10-20 parts of fried licorice root, 10-20 parts of cassia twig, 10-20 parts of clematis root, 10-20 parts of white peony root, 10-20 parts of east Asian tree fern rhizome, 2-8 parts of eucommia bark, 2-8 parts of malaytea scurfpea fruit, 2-8 parts of Chinese taxillus twig, 2-8 parts of kudzuvine root and 2-8 parts of all-grass of flaccid knotweed. The oral traditional Chinese medicine provided by the invention adopts natural Chinese medicinal herb raw materials, is simple in preparation and wide in medicine source, and keeps to a prescription medication principle of the traditional Chinese medical science; all the medicinal materials are used together to achieve the effects of clearing and activating channels and collaterals, invigorating spleen to nourish blood and relieving pain; and by virtue of clinical application verification, the oral traditional Chinese medicine is significant in effect, short in treatment course and small in toxic or side effect, can treat both symptoms and root causes, and is particularly suitable for treating lumbar vertebra hyperosteogeny.

Description

A kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny.
Background technology
Hyperosteogeny is also known as proliferative arthritis, osteoarthritis, degenerative arthritis etc., soft tissue degeneration, the degeneration such as cartilage, intervertebral disc, ligament owing to forming joint, joint margins forms bony spur, synovial membrane plumpness etc. changes and occurs osteoclasia, cause insecondary hyperosteogeny, cause joint deformity, when being subject to abnormal load, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Now, increasing people suffers from the hyperosteogeny at cervical vertebra position in various degree, and cervical vertebra is slight, and hypertrophy can cause headache, dizziness, Nausea and vomiting etc., and serious arm is numb, hurt like hell, neck harden; Lumbar vertebra is slight, and hypertrophy can cause lumbago and skelalgia, fiber crops etc., and serious causing cannot be stood, be walked, and even sleep cannot complete and stand up action.
At present, medicine and the method for the treatment of above-mentioned disease are a lot, have Chinese traditional treatment and western medical treatment, also have therapy of combining Chinese and Western medicine.Its Chinese medicine and western medicine generally adopts Salicylic Acid Formulations and on-steroidal preparation with alleviating pain, diminishes inflammation, and toxic and side effects is comparatively large, unsuitable long-term taking, and can only alleviating pain, cures the symptoms, not the disease; The Therapeutic Method of the traditional Chinese medical science to this type of disease is more, as dispeled the wind, cold expelling, dehumidify, moisturize, heat clearing away, pathogenic fire purging etc., although have certain therapeutical effect, take effect slow, the time is long, effect is undesirable.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide a kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny of rapid-action, short treating period, treating both the principal and secondary aspects of a disease.
In order to achieve the above object, the technical scheme that the present invention takes is:
A kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny, its component is by weight: Radix Glycyrrhizae Preparata 10 ~ 20 parts, Ramulus Cinnamomi 10 ~ 20 parts, Radix Clematidis 10 ~ 20 parts, the Radix Paeoniae Alba 10 ~ 20 parts, Rhizoma Cibotii 10 ~ 20 parts, the Cortex Eucommiae 2 ~ 8 parts, Fructus Psoraleae 2 ~ 8 parts, Herba Taxilli 2 ~ 8 parts, Radix Puerariae 2 ~ 8 parts, Herba Polygoni flaccidi 2 ~ 8 parts.
As preferred component, its component is by weight: Radix Glycyrrhizae Preparata 12 ~ 18 parts, Ramulus Cinnamomi 12 ~ 18 parts, Radix Clematidis 12 ~ 18 parts, the Radix Paeoniae Alba 12 ~ 18 parts, Rhizoma Cibotii 12 ~ 18 parts, the Cortex Eucommiae 3 ~ 7 parts, Fructus Psoraleae 3 ~ 7 parts, Herba Taxilli 3 ~ 7 parts, Radix Puerariae 3 ~ 7 parts, Herba Polygoni flaccidi 3 ~ 7 parts.
As preferred component, its component is by weight: Radix Glycyrrhizae Preparata 14 ~ 16 parts, Ramulus Cinnamomi 14 ~ 16 parts, Radix Clematidis 14 ~ 16 parts, the Radix Paeoniae Alba 14 ~ 16 parts, Rhizoma Cibotii 14 ~ 16 parts, the Cortex Eucommiae 4 ~ 6 parts, Fructus Psoraleae 4 ~ 6 parts, Herba Taxilli 4 ~ 6 parts, Radix Puerariae 4 ~ 6 parts, Herba Polygoni flaccidi 4 ~ 6 parts.
As better composition, its component is by weight: Radix Glycyrrhizae Preparata 15 parts, Ramulus Cinnamomi 15 parts, Radix Clematidis 15 parts, the Radix Paeoniae Alba 15 parts, Rhizoma Cibotii 15 parts, the Cortex Eucommiae 5 parts, Fructus Psoraleae 5 parts, Herba Taxilli 5 parts, Radix Puerariae 5 parts, Herba Polygoni flaccidi 5 parts.
Instructions of taking: 1 day 1 dose, adding water and decoct, point sooner or later to take for twice, 4 weeks is 1 course for the treatment of, continuously 2 courses for the treatment of of treatment.
Medicine of the present invention has following pharmacology:
Radix Glycyrrhizae Preparata, the property of medicine is sweet, flat, there is effect of QI invigorating invigorating middle warmer, relieving spasm to stop pain, nourishing the lung to arrest cough, eliminating fire and detoxication, coordinating the actions of various ingredients in a prescription, be mainly used in asthenia lack of appetite, the symptom such as leanness yellowish complexion, shortness of breath and palpitation, stomachache loose stool, the anxious pain of extremity contraction, hysteria, cough and asthma, laryngopharynx swelling and pain, carbuncle skin ulcer swell and ache, infantile carbuncle, medicine and alimentary toxicosis.
Ramulus Cinnamomi, the property of medicine is pungent, sweet, warm in nature, has effect of expelling cold and relieving exterior syndrome, promoting the flow of QI-blood by warming the meridian, activating YANG and prormoting functioning of QI, is mainly used in the symptoms such as exterior syndrome due to wind-cold, arthralgia due to cold-dampnes, extreme cold of the limbs, amenorrhea dysmenorrhea, mass in the abdomen caking, the thoracic obstruction, cardiopalmus, phlegm retention, dysuria.
Radix Clematidis, property of medicine acrid in the mouth, salty, micro-hardship, warm in nature, mild toxicity, there is effect of expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, be mainly used in rheumatic arthralgia, numb limbs and tense tendons, the contracture of muscle arteries and veins, joint stuffiness, beriberi swells and ache, malaria, bone choke with sobs larynx and control phlegm retention and the symptom such as to gather.
The Radix Paeoniae Alba, the property of medicine is bitter, acid, be slightly cold, have nourish blood and seek, effect of relieving spasm to stop pain, yin fluid astringing suppressing the hyperactive liver, be mainly used in through uncomfortable, abdominal pain during menstruation, metrorrhagia, spontaneous perspiration, night sweat, side of body rib epigastric pain, limb pain twin, headache, the symptom such as dizzy.
Rhizoma Cibotii, the property of medicine is bitter, sweet, warm, has the effect except rheumatism, strong waist foot, sharp joint, is mainly used in the symptoms such as lumbago due to renal deficiency back rigidity, sufficient knee joint weakness, rheumatic arthralgia, frequent micturition, seminal emission, leukorrhagia.
The Cortex Eucommiae, the property of medicine is sweet, micro-pungent, warm in nature, has invigorating the liver and kidney, bone and muscle strengthening, antiabortive effect, is mainly used in the symptoms such as spinal column ache, sexual impotence, frequent micturition, dribbling urination, rheumatic arthralgia, frequent fetal movement, habitual abortion.
Fructus Psoraleae, property of medicine acrid in the mouth, hardship, warm in nature, there is reinforcing the kidney and supporting YANG, helping inspiration to relieve asthma, warming spleen and stopping diarrha effect, be mainly used in the symptoms such as insufficiency of kidney-YANG, below element deficiency and cold, chills and pain of the waist and kness, sexual impotence essence, frequent micturition, the enuresis, failure of the kidney in receiving QI, dyspnea due to deficiency are more than, asthenia of both the spleen and kidney, stool chronic diarrhea, vitiligo, alopecia areata, psoriasis.
Herba Taxilli, mild in medicine property, bitter in the mouth, sweet, there is effect of invigorating the liver and kidney, bone and muscle strengthening, wind-damp dispelling, antiabortive unit, be mainly used in that rheumatic arthralgia, soreness of the waist and knees, muscles and bones are unable, metrorrhagia is through symptoms such as many, blood leaking in gestation, frequent fetal movement, hypertension.
Radix Puerariae, the property of medicine is sweet, pungent, flat, there is expelling pathogenic factors from muscles for reducing heat, deliver examine, effect of promoting the production of body fluid to quench thirst, yang invigorating antidiarrheal, be mainly used in fever caused by exogenous pathogens, rigidity pain on the head and nape, measles from the beginning of, rash go out smooth, epidemic febrile disease is thirsty, diabetes, have loose bowels, the symptom such as dysentery, hypertension, coronary heart disease.
Herba Polygoni flaccidi, the property of medicine is pungent, warm in nature, there is effect of removing toxic substances, dehumidifying, dissipating blood stasis, hemostasis, be mainly used in dysentery, have loose bowels, tonsillitis, malaria, rheumatic arthralgia, treating swelling and pain by traumatic injury, metrorrhagia, carbuncle furuncle, scrofula, venom, eczema, tinea pedis, the symptom such as traumatic hemorrhage.
Compared with prior art, the benefit that the present invention has: the present invention adopts natural Chinese medicine raw material, preparation is simple, medicine source is extensive, it follows the prescriptions principle of the traditional Chinese medical science, and all medicines share, and plays the effect of the easypro network that stimulates the menstrual flow, spleen reinforcing benefit blood, pain relieving, verify through clinical practice, its onset is remarkable, short treating period, and toxic and side effects is little, treating both the principal and secondary aspects of a disease, is particularly suitable for the use for the treatment of lumbar vertebra hyperosteogeny.
Below in conjunction with clinical laboratory data, beneficial effect of the present invention is described:
Patient data: patient 40 example, wherein man 27 example, female 13 example, at 39 ~ 66 years old age, is divided at random: treatment group and each 20 examples of matched group, treatment group takes Chinese medicine composition of the present invention, every day 1 dose, a point morning and evening takes for twice, matched group oral ibuprofen, every day 3 times, 1 time 1, two groups is all 4 weeks is 1 course for the treatment of, takes 2 courses for the treatment of continuously.Two groups of data there was no significant differences such as sex, age, have comparability.
Efficacy determination: clinical efficacy criterion, with reference to " new Chinese medicine guideline of clinical investigations ", is cured: the clinical symptoms such as pain disappear completely, and joint function recovery is normal; Effective: the clinical symptoms such as pain are obviously alleviated, function of joint is recovered substantially; Effective: the clinical symptoms such as pain are alleviated to some extent, function of joint makes moderate progress; Invalid: clinical symptoms and function of joint are not improved, and even increase the weight of.
Therapeutic effect: Clinical efficacy comparison statistical table is as shown in the table
Group Number of cases Recovery from illness Effective Effectively Invalid Total effective rate
Treatment group 20 12 17 10 1 97.5%
Matched group 20 8 14 9 8 80%
Visible, treatment group total effective rate, cure rate are significantly higher than matched group, and difference all has significant.Chinese medicine of the present invention effectively can treat lumbar vertebra hyperosteogeny.
Model case:
Case 1: Liu, female, 45 years old, hyperosteogeny patient, hyperosteogeny causes headache, dizziness, Nausea and vomiting, and right shoulder continues dull pain, stupid fiber crops, trapezius muscle spasm, is afraid of cold, shoulder joint, arm movable function is limited and day by day increase the weight of, and climate change pain increases the weight of, time serious, bend elbow hands and can not touch ipsilateral shoulder, can not complete elbow action in the wrong when stretching after arm, cisco unity malfunction, cardiopalmus tinnitus, pale tongue with white fur, pulse condition are thin and delicate.Once took Chinese and western drugs and other ointment of external application, symptom does not have clear improvement.After taking 3 courses for the treatment of of plaster of the present invention, shoulder arm pain relief, trapezius muscle spasm is clearly better, and can complete elbow in the wrong movable, the dyskinesia alleviates; After continuing to take 2 courses for the treatment of, pain symptom, trapezius muscle spasm disappear substantially, have rosy cheeks, energy is clearly better; Continue to take 1 course for the treatment of to consolidate, above-mentioned symptom disappears completely, movable accessible, follows up a case by regular visits to without recurrence.
Case 2: grandson, man, 38 years old, waist persistence dull pain, joint tingling, with the waist spasm sample severe pain of burst, to bend over difficulty, be afraid of cold, compressing right side skelalgia, intermittent claudication, numbness, become thin, weak, can not work, patient is difficult to stand, need lie in bed position breath, have a strong impact on live and work, dimly red tongue, white and thin fur, stringy and hesitant pulse.Once took Chinese and western drugs, above-mentionedly all not improve.After taking 2 courses for the treatment of of medicine of the present invention, namely pain slow down, after continuing to take 1 course for the treatment of, low-back pain obviously alleviates, and waist activity takes a turn for the better, skelalgia transference cure, after taking half course for the treatment of again, low-back pain disappears, and bend over, leg movements recovers normal, energy takes a turn for the better, appetite is normal, complexion turns ruddy, recovers normally to work, and follows up a case by regular visits to without recurrence.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is further described.
Embodiment 1
First, take each component in proportion: Radix Glycyrrhizae Preparata 20 parts, Ramulus Cinnamomi 20 parts, Radix Clematidis 20 parts, the Radix Paeoniae Alba 10 parts, Rhizoma Cibotii 10 parts, the Cortex Eucommiae 2 parts, Fructus Psoraleae 2 parts, Herba Taxilli 2 parts, Radix Puerariae 7 parts, Herba Polygoni flaccidi 7 parts.
Instructions of taking: 1 day 1 dose, adding water and decoct, point sooner or later to take for twice, 4 weeks is 1 course for the treatment of, continuously 2 courses for the treatment of of treatment.
Embodiment 2
First, take each component in proportion: Radix Glycyrrhizae Preparata 18 parts, Ramulus Cinnamomi 18 parts, Radix Clematidis 18 parts, the Radix Paeoniae Alba 12 parts, Rhizoma Cibotii 12 parts, the Cortex Eucommiae 4 parts, Fructus Psoraleae 4 parts, Herba Taxilli 4 parts, Radix Puerariae 5 parts, Herba Polygoni flaccidi 5 parts.
Instructions of taking: with embodiment 1.
Embodiment 3
First, take each component in proportion: Radix Glycyrrhizae Preparata 15 parts, Ramulus Cinnamomi 15 parts, Radix Clematidis 15 parts, the Radix Paeoniae Alba 15 parts, Rhizoma Cibotii 15 parts, the Cortex Eucommiae 5 parts, Fructus Psoraleae 5 parts, Herba Taxilli 5 parts, Radix Puerariae 5 parts, Herba Polygoni flaccidi 5 parts.
Instructions of taking: with embodiment 1.
Embodiment 4
First, take each component in proportion: Radix Glycyrrhizae Preparata 13 parts, Ramulus Cinnamomi 13 parts, Radix Clematidis 13 parts, the Radix Paeoniae Alba 17 parts, Rhizoma Cibotii 17 parts, the Cortex Eucommiae 7 parts, Fructus Psoraleae 7 parts, Herba Taxilli 7 parts, Radix Puerariae 3 parts, Herba Polygoni flaccidi 3 parts.
Instructions of taking: with embodiment 1.
Embodiment 5
First, take each component in proportion: Radix Glycyrrhizae Preparata 11 parts, Ramulus Cinnamomi 11 parts, Radix Clematidis 10 parts, the Radix Paeoniae Alba 20 parts, Rhizoma Cibotii 20 parts, the Cortex Eucommiae 8 parts, Fructus Psoraleae 8 parts, Herba Taxilli 8 parts, Radix Puerariae 2 parts, Herba Polygoni flaccidi 2 parts.
Instructions of taking: with embodiment 1.
It should be pointed out that above case is only the representational example of the present invention.Obviously, technical scheme of the present invention is not limited to above-described embodiment, can also have many degeneration.

Claims (4)

1. one kind is used for the treatment of the Chinese medicine for oral administration of lumbar vertebra hyperosteogeny, it is characterized in that, its component is by weight: Radix Glycyrrhizae Preparata 10 ~ 20 parts, Ramulus Cinnamomi 10 ~ 20 parts, Radix Clematidis 10 ~ 20 parts, the Radix Paeoniae Alba 10 ~ 20 parts, Rhizoma Cibotii 10 ~ 20 parts, the Cortex Eucommiae 2 ~ 8 parts, Fructus Psoraleae 2 ~ 8 parts, Herba Taxilli 2 ~ 8 parts, Radix Puerariae 2 ~ 8 parts, Herba Polygoni flaccidi 2 ~ 8 parts.
2. a kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny according to claim 1, it is characterized in that, its component is by weight: as preferred component, its component is by weight: Radix Glycyrrhizae Preparata 12 ~ 18 parts, Ramulus Cinnamomi 12 ~ 18 parts, Radix Clematidis 12 ~ 18 parts, the Radix Paeoniae Alba 12 ~ 18 parts, Rhizoma Cibotii 12 ~ 18 parts, the Cortex Eucommiae 3 ~ 7 parts, Fructus Psoraleae 3 ~ 7 parts, Herba Taxilli 3 ~ 7 parts, Radix Puerariae 3 ~ 7 parts, Herba Polygoni flaccidi 3 ~ 7 parts.
3. a kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny according to claim 2, it is characterized in that, its component is by weight: Radix Glycyrrhizae Preparata 14 ~ 16 parts, Ramulus Cinnamomi 14 ~ 16 parts, Radix Clematidis 14 ~ 16 parts, the Radix Paeoniae Alba 14 ~ 16 parts, Rhizoma Cibotii 14 ~ 16 parts, the Cortex Eucommiae 4 ~ 6 parts, Fructus Psoraleae 4 ~ 6 parts, Herba Taxilli 4 ~ 6 parts, Radix Puerariae 4 ~ 6 parts, Herba Polygoni flaccidi 4 ~ 6 parts.
4. a kind of Chinese medicine for oral administration being used for the treatment of lumbar vertebra hyperosteogeny according to claim 3, it is characterized in that, its component is by weight: Radix Glycyrrhizae Preparata 15 parts, Ramulus Cinnamomi 15 parts, Radix Clematidis 15 parts, the Radix Paeoniae Alba 15 parts, Rhizoma Cibotii 15 parts, the Cortex Eucommiae 5 parts, Fructus Psoraleae 5 parts, Herba Taxilli 5 parts, Radix Puerariae 5 parts, Herba Polygoni flaccidi 5 parts.
CN201510847898.0A 2015-11-30 2015-11-30 Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny Pending CN105267324A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510847898.0A CN105267324A (en) 2015-11-30 2015-11-30 Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510847898.0A CN105267324A (en) 2015-11-30 2015-11-30 Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny

Publications (1)

Publication Number Publication Date
CN105267324A true CN105267324A (en) 2016-01-27

Family

ID=55137721

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510847898.0A Pending CN105267324A (en) 2015-11-30 2015-11-30 Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny

Country Status (1)

Country Link
CN (1) CN105267324A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107737330A (en) * 2017-12-15 2018-02-27 河南中医药大学 A kind of Chinese medicinal lotion for treating postpartum pain of body

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104815263A (en) * 2015-04-27 2015-08-05 朱道明 Plaster for treating osteoproliferation of cervical vertebra and lumbar vertebra

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104815263A (en) * 2015-04-27 2015-08-05 朱道明 Plaster for treating osteoproliferation of cervical vertebra and lumbar vertebra

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107737330A (en) * 2017-12-15 2018-02-27 河南中医药大学 A kind of Chinese medicinal lotion for treating postpartum pain of body

Similar Documents

Publication Publication Date Title
CN103285200B (en) Traditional Chinese medicine for treating multiple osteopathies
CN103393862A (en) Chinese medicinal composition for treating lumbocrural pain
CN102626505A (en) Massaging paste based on Chinese medicinal herbs and preparation method thereof
CN102908414B (en) External use plaster for treating fracture and traumatic injury
CN104815263A (en) Plaster for treating osteoproliferation of cervical vertebra and lumbar vertebra
CN104027609A (en) Plaster for treating rheumatoid bone diseases, joint pains and muscle injuries
CN105267324A (en) Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny
CN103550383A (en) Traditional Chinese medicine composition for treating cervical spondylosis
CN103301430A (en) Medicament for treating hyperostosis and pain in waist and lower extremities and preparation method thereof
CN103599233B (en) Bone hyperplasia rehabilitation medicinal liquor
CN102764336B (en) Traditional Chinese medicine for curing bone trauma
CN102028768B (en) Traditional Chinese medicament for treating lumbar canal stenosis
CN105287731A (en) Externally-applied traditional Chinese medicine preparation for treating hyperostosis and preparation method thereof
CN101695559B (en) Ointment for treating osteoarthropathy and preparation method thereof
CN1267127C (en) Osteoproliferation medicine for external application
CN106421255B (en) External Chinese herbal medicine composition and application thereof
CN104644928A (en) Medicine for treating cervical and lumbar disc herniations
CN104491828A (en) Warming pain relief Chinese materia medica preparation and paste preparing method thereof
CN110538272A (en) swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof
CN103550471A (en) Traditional Chinese medicine (TCM) composition for treating Bi pain
CN107582781A (en) A kind of Externally applied Chinese medicine wax moxibustion for treating lumbar vertebra disease
CN101028472B (en) Oral Chinese medicinal composition for treating lumbocostal overstrain
CN104208611A (en) External-applying traditional Chinese medicine powder for injuries in bone and tendon and use method thereof
CN103751510A (en) Traditional Chinese medicine composition for treating femoral head necrosis
CN108295238A (en) It is a kind of treat four limbs, joint of lumbar vertebra pain Chinese medicine composition and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20160127